Question 1

What are systemic immune-inflammatory markers, and how do they relate to my cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma clinical trial (NCT05025371). Contact the study team or your healthcare provider for specific answers.

Question 2

How could these markers help predict my survival after surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma clinical trial (NCT05025371). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there other tests or treatments available that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma clinical trial (NCT05025371). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the research say about the effectiveness of these markers in predicting outcomes?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma clinical trial (NCT05025371). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to be monitored for these markers after surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma clinical trial (NCT05025371). Contact the study team or your healthcare provider for specific answers.

What this study is about